|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Patent
DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
14.05.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
CSE: DTC FSE: DTC US... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Miscellaneous
PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM002 ANTICANCER VACCINE
02.05.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
__________... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Miscellaneous
DEFENCE’S ACCUTOX ANTICANCER ARM002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION
23.04.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Vancouver, BC, Canada, April 23rd, 2024 Defence... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Financing
DEFENCE THERAPEUTICS SIGNS WITH GERMAN BASED FMS CONSULT GMBH FOR FINANCING STRATEGY TO SUPPORT DEFENCE PIPELINE GROWTH
17.04.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
CSE: DTC FSE:... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Miscellaneous
ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®ARMTMVAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM002TMKREBSIMPFSTOFFS DER ZWEITEN GENERATION
26.03.2024 / 13:30 CET/CEST
The issuer is solely responsible for the content of this... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Product Launch
DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTICANCER ARMTM VACCINE CREATES A POTENT SECONDGENERATION ANTICANCER ARM002TM VACCINE
26.03.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Defence Therapeutics Inc.
/ Key words: Miscellaneous
DEFENCE THERAPEUTICS AWARDED BROAD U.S. PATENT COVERING ITS PIONEERING CANCERKILLING ACCUTOX® TECHNOLOGY
04.03.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
___________________________... Lire le communiqué |
|
| |
|
| |
